Compare FIS & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIS | DXCM |
|---|---|---|
| Founded | 1968 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0B | 31.7B |
| IPO Year | N/A | 2005 |
| Metric | FIS | DXCM |
|---|---|---|
| Price | $65.30 | $66.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 21 |
| Target Price | $85.50 | ★ $87.81 |
| AVG Volume (30 Days) | 2.9M | ★ 5.4M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | N/A | ★ 7.75 |
| EPS | 0.29 | ★ 1.80 |
| Revenue | ★ $10,464,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $5.80 | $17.41 |
| Revenue Next Year | $4.55 | $12.78 |
| P/E Ratio | $225.01 | ★ $36.92 |
| Revenue Growth | 4.21 | ★ 14.21 |
| 52 Week Low | $59.51 | $54.11 |
| 52 Week High | $85.85 | $93.25 |
| Indicator | FIS | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 62.84 |
| Support Level | $64.91 | $64.00 |
| Resistance Level | $66.93 | $66.75 |
| Average True Range (ATR) | 1.41 | 1.89 |
| MACD | 0.17 | 0.84 |
| Stochastic Oscillator | 57.12 | 94.81 |
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.